• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Menopausal hormone therapy in patients with a history of gynecologic cancer.

作者信息

Kotait Maryam, Shea Alison, Nguyen Julie M V

机构信息

Department of Obstetrics and Gynecology (Kotait, Shea); Division of Gynecologic Oncology, Department of Obstetrics and Gynecology (Nguyen), McMaster University, Hamilton, Ont.

出版信息

CMAJ. 2023 Dec 17;195(49):E1721. doi: 10.1503/cmaj.231066.

DOI:10.1503/cmaj.231066
PMID:38110209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10727789/
Abstract
摘要

相似文献

1
Menopausal hormone therapy in patients with a history of gynecologic cancer.有妇科癌症病史患者的绝经激素治疗
CMAJ. 2023 Dec 17;195(49):E1721. doi: 10.1503/cmaj.231066.
2
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.欧洲绝经学会（EMAS）和国际妇科肿瘤学会（IGCS）关于妇科癌症后管理绝经的立场声明：关注绝经症状和骨质疏松症。
Maturitas. 2020 Apr;134:56-61. doi: 10.1016/j.maturitas.2020.01.005. Epub 2020 Feb 11.
3
Hormone replacement therapy in gynecologic cancer survivors: why not?妇科癌症幸存者的激素替代疗法：为什么不？
Gynecol Oncol. 2011 Aug;122(2):447-54. doi: 10.1016/j.ygyno.2011.03.012. Epub 2011 Apr 6.
4
Depression after menopause and the use of menopausal hormone therapy.绝经后抑郁症与绝经激素治疗的应用
Maturitas. 2023 May;171:53-54. doi: 10.1016/j.maturitas.2022.12.005. Epub 2022 Dec 24.
5
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.欧洲绝经学会（EMAS）和国际妇科肿瘤学会（IGCS）关于妇科癌症后管理绝经的立场声明：关注绝经症状和骨质疏松症。
Int J Gynecol Cancer. 2020 Apr;30(4):428-433. doi: 10.1136/ijgc-2020-001217. Epub 2020 Feb 11.
6
Management of menopausal symptoms in women with gynecologic cancers.妇科癌症女性更年期症状的管理。
Gynecol Oncol. 2017 Aug;146(2):427-435. doi: 10.1016/j.ygyno.2017.06.013. Epub 2017 Jun 16.
7
Estrogen and combined hormone therapy for women after genital malignancies: a review.雌激素及联合激素疗法用于生殖器恶性肿瘤术后女性的研究综述
J Reprod Med. 2004 Oct;49(10):837-48.
8
Estrogen and progesterone in breast and gynecologic cancers. Etiology, therapeutic role, and hormone replacement.雌激素和孕激素与乳腺癌及妇科癌症。病因、治疗作用及激素替代疗法。
Obstet Gynecol Clin North Am. 1994 Jun;21(2):245-70.
9
Menopausal hormone therapy after breast cancer.乳腺癌后的绝经激素治疗。
Lancet. 2004 Feb 7;363(9407):410-1. doi: 10.1016/S0140-6736(04)15519-0.
10
Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.癌症幸存者的激素替代疗法——文献综述。
Pathol Oncol Res. 2020 Jan;26(1):63-78. doi: 10.1007/s12253-018-00569-x. Epub 2019 Jan 8.

本文引用的文献

1
The 2022 hormone therapy position statement of The North American Menopause Society.北美绝经学会 2022 年激素治疗立场声明。
Menopause. 2022 Jul 1;29(7):767-794. doi: 10.1097/GME.0000000000002028.
2
Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement: This practice statement has been endorsed by The North American Menopause Society.妇科癌症女性及患妇科癌症高危女性的激素治疗：妇科肿瘤学会（SGO）临床实践声明：本实践声明已获北美更年期协会认可。
Gynecol Oncol. 2020 May;157(2):303-306. doi: 10.1016/j.ygyno.2020.01.035. Epub 2020 Feb 15.
3
Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.上皮性卵巢癌患者的术后激素替代疗法：一项系统评价和荟萃分析。
Gynecol Oncol. 2015 Nov;139(2):355-62. doi: 10.1016/j.ygyno.2015.07.109. Epub 2015 Jul 29.
4
Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis.激素替代疗法对子宫内膜癌幸存者复发率的影响：一项荟萃分析。
Eur J Cancer. 2014 Jun;50(9):1628-37. doi: 10.1016/j.ejca.2014.03.006. Epub 2014 Mar 28.
5
Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.雌激素替代疗法与安慰剂治疗Ⅰ期或Ⅱ期子宫内膜癌的随机双盲试验：一项妇科肿瘤学组研究
J Clin Oncol. 2006 Feb 1;24(4):587-92. doi: 10.1200/JCO.2005.02.8464.